HOME > NEWS > Content

Azvudine Tablets, a Domestic Oral Novel-Coronavirus Drug invented by Professor Chang Junbiao of ZZU, has been Included in the COVID-19 Diagnosis and Treatment Plan

Publisher:   From:zzu   Publish Date:2022-10-10   Read Count:

On August 9th, the General Office of the National Health Commission and the Office of the National Administration of Traditional Chinese Medicine issued the "Notice on Including Azvudine Tablets in the Diagnosis and Treatment Plan of COVID-19".

The Notice noted that the drug has been included in the "COVID-19 Diagnosis and Treatment Plan (Ninth Edition)" according to the National Medical Products Administration’s conditional approval of the registration application for the increasing indications for the treatment of COVID-19 of Azvudine tablets.


PREV:The Third Affiliated Hospital of ZZU Achieved Excellent Results in the Performance Evaluation of Tertiary Public Hospitals in China
NEXT:The First Affiliated Hospital of Zhengzhou University is shortlisted as a potential unit of Artificial Intelligence Medical Device Innovation task

郑州大学医学院官方微信
扫一扫在手机打开当前页
郑州大学官方微信

Address:40 North Road, 27 District University, Zhengzhou  ZIP code:450052    Tel:0371-66658007/66658829    Email:yxyzhb@zzu.edu.cn 
   Copyright @2019 Zhengzhou University School of Medicine All Right Reserved

Page View: